Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1441192

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1441192

Global Antimicrobial Susceptibility Testing Market Size, Share, Growth Analysis, By Test type, By End user, By Product type - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Antimicrobial Susceptibility Testing Market size was valued at USD 3.60 Billion in 2022 and is poised to grow from USD 3.79 Billion in 2023 to USD 5.68 Billion by 2031, at a CAGR of 5.20% during the forecast period (2024-2031).

The global Antimicrobial Susceptibility Testing (AST) Market is experiencing notable growth, fueled by the rising prevalence of antimicrobial resistance and the imperative for effective treatment strategies. AST plays a pivotal role in assisting clinicians in choosing appropriate antimicrobial therapies, ensuring optimal treatment outcomes, and addressing the surge of drug-resistant pathogens. Its primary objective is to furnish accurate and timely information on microorganisms' susceptibility to various antibiotics. AST empowers healthcare professionals to make informed decisions regarding antibiotic selection, dosage, and treatment duration, contributing to the proficient management of infectious diseases. By identifying the most effective antibiotics, AST facilitates personalized treatment plans, mitigates the risk of treatment failure, and supports antimicrobial stewardship initiatives. Several key factors are propelling the growth of the antimicrobial susceptibility testing market. The escalating burden of antimicrobial resistance, leading to increased morbidity, mortality, and healthcare costs, propels the demand for AST. Furthermore, the upsurge in infectious disease outbreaks, hospital-acquired infections, and heightened awareness of the necessity for targeted therapies drive market expansion. The introduction of rapid AST methods, automation, and the integration of molecular diagnostics into AST systems further stimulate market growth. Nevertheless, challenges such as limited access to advanced AST methods in resource-constrained settings, high implementation costs for sophisticated testing technologies, the intricacy of interpreting test results, difficulties in standardizing testing methods, and the time-consuming nature of traditional AST methods may impede market growth. Key trends in the antimicrobial susceptibility testing market involve the development of rapid and precise AST systems, the incorporation of artificial intelligence (AI) and machine learning algorithms for data analysis, and an increased focus on multiplex testing to detect multiple drug resistance patterns simultaneously. The market also presents substantial opportunities for growth and innovation, including the rising demand for point-of-care testing, the adoption of automated AST systems in laboratories, and the growing emphasis on personalized medicine in infectious disease management. Collaborations between diagnostic companies, research institutions, and healthcare organizations are anticipated to drive advancements in AST technologies and expand market reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Susceptibility Testing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Susceptibility Testing Market Segmental Analysis

Global Antimicrobial Susceptibility Testing Market is segmented on the basis of test type, end user, product type, and region. By test type, the market is segmented into phenotypic testing, genotypic testing, and rapid testing. By end user, the market is segmented into hospitals and diagnostic laboratories, research and academic institutes, and pharmaceutical and biotechnology companies. By product type, the market is segmented into Instruments, reagents and kits, and software and services. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Antimicrobial Susceptibility Testing Market

The surge in antimicrobial resistance stands out as a major catalyst for the Antimicrobial Susceptibility Testing (AST) market. The advent of drug-resistant pathogens poses a grave and widespread threat to public health. A noteworthy example is the escalating prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infections, underscoring the critical necessity for precise AST. This need arises to guide clinicians in making informed decisions regarding the selection of suitable antibiotics for effective treatment.

Restraints in the Global Antimicrobial Susceptibility Testing Market

Limited access to advanced Antimicrobial Susceptibility Testing (AST) technologies in resource-constrained settings poses a hindrance to market growth. For instance, low-income countries may encounter difficulties in adopting automated AST systems due to their elevated costs and the requirement for adequately trained personnel.

Market Trends of the Global Antimicrobial Susceptibility Testing Market

The incorporation of artificial intelligence (AI) and machine learning algorithms for analyzing Antimicrobial Susceptibility Testing (AST) data is an expanding trend. These technologies play a crucial role in deciphering intricate datasets, enhancing the precision, and expediting the interpretation of AST results. An illustrative instance is the AI-powered platform DeepAMR, which utilizes machine learning to forecast bacterial susceptibility to antibiotics by leveraging genomic data.

Product Code: SQMIG35B2120

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Antimicrobial Susceptibility Testing Market by Test type

  • Market Overview
  • Phenotypic testing
  • genotypic testing
  • and rapid testing

Global Antimicrobial Susceptibility Testing Market by End user

  • Market Overview
  • Hospitals and diagnostic laboratories
  • research and academic institutes
  • and pharmaceutical and biotechnology companies

Global Antimicrobial Susceptibility Testing Market by Product type

  • Market Overview
  • Instruments
  • reagents and kits
  • and software and services

Global Antimicrobial Susceptibility Testing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Liofilchem s.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accelerate Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synbiosis (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ELITechGroup (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!